Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy
- PMID: 23001953
- PMCID: PMC5971105
- DOI: 10.1177/1098612X12460847
Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy
Abstract
An interplay between growth, glucose regulation and hypertrophic cardiomyopathy (HCM) may exist, but has not been studied in detail. The purpose of this study was to characterize morphometric features, insulin-like growth factor-1 (IGF-1) and glucose metabolism in Maine Coon cats with HCM. Body weight, body condition score (BCS), head length and width, and abdominal circumference were measured in Maine Coon cats >2 years of age. Echocardiography and thoracic radiography (for measurement of humerus length, and fourth and twelfth vertebrae length) were also performed. Blood was collected for biochemistry profile, DNA testing, insulin and IGF-1. Sixteen of 63 cats had HCM [myosin binding protein C (MYBPC)+, n = 3 and MYBPC-, n = 13] and 47/63 were echocardiographically normal (MYBPC+, n = 17 and MYBPC-, n = 30). There were no significant differences in any measured parameter between MYBPC+ and MYBPC- cats. Cats with HCM were significantly older (P <0.001), heavier (P = 0.006), more obese (P = 0.008), and had longer humeri (P = 0.02) compared with the HCM- group. Cats with HCM also had higher serum glucose (P = 0.01), homeostasis model assessment (HOMA) and IGF-1 (P = 0.01) concentrations, were from smaller litters (P = 0.04), and were larger at 6 months (P = 0.02) and at 1 year of age (P = 0.03). Multivariate analysis revealed that age (P <0.001), BCS (P = 0.03) and HOMA (P = 0.047) remained significantly associated with HCM. These results support the hypothesis that early growth and nutrition, larger body size and obesity may be environmental modifiers of genetic predisposition to HCM. Further studies are warranted to evaluate the effects of early nutrition on the phenotypic expression of HCM.
Conflict of interest statement
The authors do not have any potential conflicts of interest to declare.
Similar articles
-
Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy.Am J Vet Res. 2008 Aug;69(8):1061-6. doi: 10.2460/ajvr.69.8.1061. Am J Vet Res. 2008. PMID: 18672971
-
Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.J Vet Cardiol. 2009 May;11 Suppl 1:S63-70. doi: 10.1016/j.jvc.2009.02.005. Epub 2009 Apr 22. J Vet Cardiol. 2009. PMID: 19395334
-
Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats.J Vet Intern Med. 2010 May-Jun;24(3):527-32. doi: 10.1111/j.1939-1676.2010.0514.x. Epub 2010 Apr 16. J Vet Intern Med. 2010. PMID: 20412438
-
The genetic basis of hypertrophic cardiomyopathy in cats and humans.J Vet Cardiol. 2015 Dec;17 Suppl 1(Suppl 1):S53-73. doi: 10.1016/j.jvc.2015.03.001. J Vet Cardiol. 2015. PMID: 26776594 Free PMC article. Review.
-
Genetic Basis of Hypertrophic Cardiomyopathy in Cats.Curr Issues Mol Biol. 2024 Aug 12;46(8):8752-8766. doi: 10.3390/cimb46080517. Curr Issues Mol Biol. 2024. PMID: 39194734 Free PMC article. Review.
Cited by
-
Feline Comorbidities: Hypersomatotropism-induced diabetes in cats.J Feline Med Surg. 2024 Feb;26(2):1098612X241226690. doi: 10.1177/1098612X241226690. J Feline Med Surg. 2024. PMID: 38323402 Free PMC article. Review.
-
Strong associations of nine-point body condition scoring with survival and lifespan in cats.J Feline Med Surg. 2018 Dec;20(12):1110-1118. doi: 10.1177/1098612X17752198. Epub 2018 Feb 2. J Feline Med Surg. 2018. PMID: 29393723 Free PMC article.
-
Body Condition Scores in Cats and Associations with Systolic Blood Pressure, Glucose Homeostasis, and Systemic Inflammation.Vet Sci. 2024 Mar 28;11(4):151. doi: 10.3390/vetsci11040151. Vet Sci. 2024. PMID: 38668418 Free PMC article.
-
Echocardiographic, morphometric and biomarker changes in female cats followed from 6 to 24 months of life.J Feline Med Surg. 2021 Apr;23(4):278-286. doi: 10.1177/1098612X20943684. Epub 2020 Jul 28. J Feline Med Surg. 2021. PMID: 32720562 Free PMC article.
-
Relationship of body size to metabolic markers and left ventricular hypertrophy in cats.J Vet Intern Med. 2015 Jan;29(1):150-6. doi: 10.1111/jvim.12503. Epub 2014 Nov 20. J Vet Intern Med. 2015. PMID: 25411091 Free PMC article.
References
-
- Gersh BJ, Maron BJ, Bonow RO, et al. . 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: 212–260. - PubMed
-
- Meurs KM, Sanchez X, David RM, et al. . A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 2005; 14: 3587–3593. - PubMed
-
- Meurs KM, Norgard MM, Ederer MM, et al. . A substitution mutation in the myosin binding protein C gene in Ragdoll hypertrophic cardiomyopathy. Genomics 2007; 90: 261–264. - PubMed
-
- Mary J, Chetboul V, Sampedrano CC, et al. . Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed. J Vet Cardiol 2010; 12: 155–161. - PubMed
-
- Peterson EN, Moise NS, Brown CA, et al. . Heterogeneity of hypertrophy in feline hypertrophic heart disease. J Vet Intern Med 1993; 7: 183–189. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous